About
GLX Analytix develops a clinical-stage blood test platform that uses AI to measure glycocalyx sugar fragments in blood, enabling diagnosis and monitoring of neuropsychiatric, neurodegenerative, and autoimmune brain diseases.
Explore GLX Analytix's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.